Home
Name
MFP
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for MFP
Name
Alternate Names
5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596
Abbreviations
5-FU
5FU
FU
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
019893
19893
Primary Site
Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Hepatoma
Ovarian cancer
Histology
None
Remarks
Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.
Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.
Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.
Coding
This drug should be coded
Name
Alternate Names
Alanine mustard
Alkeran
CB-3025
DL Sarcolysine
DL-O-Sarcolysin
L-Phenylalanine Mustard
L-Sarcolysin
Melfalan
Phenylalanine Mustard
Sarcolysine
Sarkoklorin
Sarkolizin
WR-19813
Abbreviations
L-PAM
MPL
PAM
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
8806
008806
57199
Primary Site
Histology
None
Remarks
Alkylating antineoplastic agent. FDA approved uses on multiple myeloma and epithelial non-resectable ovarian carcinoma.
Also used in the high-dose chemotherapy and transplant setting.
Mechanism of action: Analog of nitrogen mustard
Also used in the high-dose chemotherapy and transplant setting.
Mechanism of action: Analog of nitrogen mustard
Coding
This drug should be coded
Name
Alternate Names
Alti-MPA
Amen
Curretab
Cycrin
Depcorlutin
Depo-Provera
Farlutin
Gestapuran
Lutopolar
Lutoral
Medroxypro-gesterone Acetate
Oragest
Perlutex
Proclim
Prodasone
Progestal
Provera
Proverone
Repromap
Repromix
Sirprogen
U-8839
Veramix
Abbreviations
DMPA
MAP
MPA
Category
Hormones and hormonal mechanisms
Subcategory
Progestin
NSC Number
026386
26386
Primary Site
Histology
None
Remarks
A synthetic progestogen (progestin). FDA approved palliative uses in advanced endometrial carcinoma and advanced renal cell carcinoma; administered intramuscularly. This drug lessens the tumor burden allowing for surgical treatment. If given prior to surgical treatment, code as neo-adjuvant therapy. Also used orally in the treatment of secondary amenorrhea and functional uterine bleeding and as a contraceptive.
Coding
This drug should be coded
